Skip to main content
Fig. 1 | Trials

Fig. 1

From: Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

Fig. 1

Flowchart: 90 patients will be recruited in the study and randomly allocated to three groups (high-dose group = 30; low-dose group = 30; control group = 30). The assessment will be done 24 h and 3, 6, and 12 months, respectively

Back to article page

Trials

ISSN: 1745-6215